Inhibitors of SARM1
The present disclosure provides compounds and methods useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration.
1. A compound of Formula I-c:
or a pharmaceutically acceptable salt thereof, wherein:
R 1 is selected from
R 2 is selected from the group consisting of hydrogen, halogen, and a substituted or unsubstituted C 1-6 aliphatic; and
R 3 is selected from the group consisting of hydrogen and halogen, with the proviso that the compound is not:
2. The compound according to claim 1 , wherein R 2 is halogen.
3. The compound according to claim 2 , wherein R 2 is chloro.
4. The compound according to claim 2 , wherein R 2 is bromo.
5. The compound according to claim 2 , wherein R 2 is fluoro.
6. The compound according to claim 1 , wherein R 2 is —CH 3 .
7. The compound according to claim 1 , wherein R 2 is hydrogen.
8. The compound according to claim 1 , wherein R 3 is hydrogen.
9. The compound according to claim 1 , wherein R 3 is halogen.
10. The compound according to claim 9 , wherein R 3 is chloro.